ViiV Healthcare’s innovative injectable therapy shows promise in patients with detectable HIV and no prior resistance, offering...
Medical Research and Clinical Trials
London, UK – October 26, 2023 – ViiV Healthcare, a global specialist HIV company majority-owned by GSK,...
NORMAN, OK – In a significant stride against one of the most challenging forms of cancer, new...
<header> <h1 class=”article-title”>University of Oklahoma Breakthrough Reveals How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth</h1>...
Norman, OK – In a significant stride for cancer research, scientists at the University of Oklahoma have...
Main Facts Ibuprofen, a ubiquitous over-the-counter medication, is a household staple, routinely reached for to quell headaches,...
A pivotal Phase III trial has delivered promising results, potentially reshaping the standard of care for newly...
NEW YORK, NY – January 22, 2024 – In a significant departure from conventional cancer treatment strategies,...
Vienna, Austria – The 35th European Academy of Dermatology and Venereology (EADV) annual congress, held in Vienna...
New York, NY – For decades, the presence of regulatory T (Treg) cells in solid tumors has...
